This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:

- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC
- Review updated clinical data from ELCC and ESMO 2023
- Gain an understanding around the management of treatment-related Adverse Events